meta_pixel
Tapesearch Logo
Log in
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

082 - Let’s Get Heavy! Deuterium Substitution as a Pathway for Drug Design

HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

Sean P. Kane, PharmD, BCPS

Health & Fitness, Medications, Rosalindfranklin, Rfums, Pharmacy, Pharmd, Pharmacist, Medicine, Drugs

5644 Ratings

🗓️ 7 August 2018

⏱️ 34 minutes

🧾️ Download transcript

Summary

In this episode, we take a closer look at deuteration, specifically involving the medication deutetrabenazine (discussed back in episode 76). We feature a guest contributor from our pharmacy sciences department who assists us as we look at the drug design aspects of this unique molecule and its implications for research moving forward.

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome to Helix Talk, an educational podcast for healthcare students and providers covering real-life clinical pearls, professional pharmacy topics, and drug therapy discussions.

0:11.0

This podcast is provided by pharmacists and faculty members at Rosal Franklin University College of Pharmacy.

0:17.0

This podcast contains general information for educational purposes only. This is not professional

0:22.5

advice and should not be used in lieu of obtaining advice from a qualified health care provider.

0:27.2

And now on to the show.

0:31.2

Welcome to Helix Talk episode 82. I'm your co-host Dr. Kane. I'm Dr. Schumann. I'm Dr.

0:36.7

Patel. And I'm Dr. Rahul Deshmuk. This is the very first time I'm your co-host Dr. Kane. I'm Dr. Schumann. I'm Dr. Patel. And I'm Dr. Rahul Deshmuk. This is the very

0:40.2

first time I'm joining a wonderful group of people to discuss a little more about the topic for the day.

0:46.9

Very, very happy to have you. Yeah, so I'm going to kick off today's episode. Really excited to

0:51.8

introduce, let's get heavy Deuterium Substitution as a Pathway for Drug

0:56.4

Design. Again, what we're really going to look at here is the use of deuteration, specifically

1:01.7

involving the medication dutrebenazine, which is when we discussed way back in episode 76,

1:06.8

looking at tardive dyskinesia management. Feature, again, we have our guest here, Dr. Deshmuk, looking from the pharmacy sciences

1:13.6

department at the role of this medication, not just this current medication, but really

1:18.6

as the future holds for drug design and development and some of the new concepts about,

1:25.0

you know, essentially a new paradigm in drug molecules shifting and discovery

1:29.3

for future targets. And I hope to make some contributions to this. Deuterium as a molecule

1:36.1

that is a part of this discussion today, it's not a novel molecule. And as we discuss more,

1:42.1

you'll realize that it's just a heavy isotope of hydrogen and it has a lot of

1:48.0

unique properties that are being currently exploited to see if we can get into some kind of drug

1:54.1

development with it and that's what we'll be discussing and for those listeners who are maybe a little bit

1:59.4

far removed from the pharmacy sciences courses that they took in pharmacy school, I just want to caution you here that this is stuff that is coming out right now.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Sean P. Kane, PharmD, BCPS, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Sean P. Kane, PharmD, BCPS and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.